Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry

Area of Science:

• Neuro-oncology
• Biotechnology
• Cancer Therapy

Background:

• Glioblastoma (GB) is an aggressive brain tumor with limited treatment options.
• Current standard treatments, including radiotherapy and chemotherapy with Temozolomide, are often ineffective due to tumor heterogeneity and invasiveness.
• There is a critical need for novel therapeutic strategies to improve glioblastoma patient outcomes.

Purpose of the Study:

• To review the challenges in glioblastoma treatment.
• To explore the potential of extracellular vesicles (EVs) as a therapeutic strategy for glioblastoma.
• To summarize preclinical findings on EV-based glioblastoma therapies.

Main Methods:

• Literature review of current glioblastoma treatment challenges.
• Analysis of extracellular vesicle (EV) properties and their therapeutic potential.
• Summary and analysis of preclinical in vivo studies using EVs for glioblastoma treatment.
• SWOT analysis of EV-based glioblastoma therapeutic strategies.

Main Results:

• Extracellular vesicles (EVs) are natural cell-derived particles with inherent targeting and payload delivery capabilities.
• Preclinical studies demonstrate the potential of EVs, with various sources and molecular cargoes, in targeting and treating glioblastoma models.
• EVs exhibit favorable characteristics such as stability in body fluids and immune tolerance, making them suitable for therapeutic applications.

Conclusions:

• Extracellular vesicles (EVs) represent a promising avenue for developing novel glioblastoma therapies.
• Further research and development are needed to overcome challenges and realize the full therapeutic potential of EVs in glioblastoma treatment.
• EV-based strategies could significantly improve the prognosis and quality of life for glioblastoma patients.